Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Sarcopenia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Infections 1

Interventions

pembrolizumab 49 Specimen Handling 29 Magnetic Resonance Spectroscopy 25 Biopsy 25 Radiosurgery 17 Gemcitabine 17 Nivolumab 16 Cyclophosphamide 14 Cisplatin 14 Paclitaxel 13 Carboplatin 13 Bevacizumab 13 Leucovorin 11 Irinotecan 11 Fluorouracil 11 Drug Therapy 11 Taxes 10 Radiotherapy 10 Oxaliplatin 10 Capecitabine 10 trastuzumab deruxtecan 9 fludarabine 9 cemiplimab 8 Doxorubicin 8 Cetuximab 8 abemaciclib 7 Trastuzumab 7 Pemetrexed 7 Fulvestrant 7 Docetaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × Wearable Electronic Devices × Clear all

NCT06590506 2024-09-19

HDM-PMP22

Centro Nacional de Investigaciones Oncologicas CARLOS III

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡